239
Views
8
CrossRef citations to date
0
Altmetric
Research Article

Primary systemic vasculitis with severe
α1-antitrypsin deficiency revisited

&
Pages 242-245 | Accepted 16 Sep 2013, Published online: 09 Dec 2013

References

  • Stoller JK, Aboussouan LS. Alpha1-antitrypsin deficiency. Lancet 2005;365:2225–36.
  • Esnault VL, Testa A, Audrain M, Roge C, Hamidou M, Barrier JH, et al. Alpha 1-antitrypsin genetic polymorphism in ANCA-positive systemic vasculitis. Kidney Int 1993;43:1329–32.
  • Segelmark M, Elzouki AN, Wieslander J, Eriksson S. The PiZ gene of alpha 1-antitrypsin as a determinant of outcome in PR3-ANCA-positive vasculitis. Kidney Int 1995;48:844–50.
  • Mahr AD, Edberg JC, Stone JH, Hoffman GS, St Clair EW, Specks U, et al. Alpha-antitrypsin deficiency-related alleles Z and S and the risk of Wegener’s granulomatosis. Arthritis Rheum 2010;62:3760–7.
  • Morris H, Morgan MD, Wood AM, Smith SW, Ekeowa UI, Herrmann K, et al. ANCA-associated vasculitis is linked to carriage of the Z allele of alpha antitrypsin and its polymers. Ann Rheum Dis 2011;70:1851–6.
  • Lyons PA, Rayner TF, Trivedi S, Holle JU, Watts RA, Jayne DR, et al. Genetically distinct subsets within ANCA-associated vasculitis. N Engl J Med 2012;367:214–23.
  • Mazodier P, Elzouki AN, Segelmark M, Eriksson S. Systemic necrotizing vasculitides in severe alpha1-antitrypsin deficiency. Q J Med 1996;89:599–611.
  • Elzouki AN, Segalmark M, Mazodier P, Eriksson S. Wegener’s granulomatosis in a patient with severe PiZZ alpha 1-antitrypsin deficiency. Q J Med 1996;89:877.
  • Takii Y, Inoue H, Karashima E, Akahoshi M, Furugo I, Hattori S, et al. Systemic vasculitis associated with alpha1-antitrypsin deficiency. Intern Med 2003;42:619–23.
  • Wong SC, Boyce RL, Dowd TC, Fordham JN. Bilateral central retinal artery occlusion in Wegener’s granulomatosis and alpha(1) antitrypsin deficiency. Br J Ophthalmol 2002;86: 476.
  • Lal S, Sim E, Harty J, Singhal S, Al Baaj F, Wardman A, et al. Disseminated intravascular coagulation complicating polyarteritis nodosa in alpha-1-antitrypsin deficiency. Nephrol Dial Transplant 1998;13:1553–5.
  • Mohammad AJ, Jacobsson LT, Westman KW, Sturfelt G, Segelmark M. Incidence and survival rates in Wegener’s granulomatosis, microscopic polyangiitis, Churg-Strauss syndrome and polyarteritis nodosa. Rheumatology (Oxford) 2009;48: 1560–5.
  • Laurell CB, Sveger T. Mass screening of newborn Swedish infants for alpha antitrypsin deficiency. Am J Hum Genet 1975;27:213–17.
  • Selga D, Mohammad A, Sturfelt G, Segelmark M. Polyarteritis nodosa when applying the Chapel Hill nomenclature – a descriptive study on ten patients. Rheumatology (Oxford) 2006; 45:1276–81.
  • Exley AR, Bacon PA, Luqmani RA, Kitas GD, Carruthers DM, Moots R. Examination of disease severity in systemic vasculitis from the novel perspective of damage using the vasculitis damage index (VDI). Br J Rheumatol 1998;37:57–63.
  • Pittelkow MR, Smith KC, Su WP. Alpha-1-antitrypsin deficiency and panniculitis. Perspectives on disease relationship and replacement therapy. Am J Med 1988;84:80–6.
  • Mohammad AJ, Bakoush O, Sturfelt G, Segelmark M. The extent and pattern of organ damage in small vessel vasculitis measured by the Vasculitis Damage Index (VDI). Scand J Rheumatol 2009; 38:268–75.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.